PT - JOURNAL ARTICLE AU - Lei, Jiayao AU - Clements, Mark AU - Elfström, Miriam AU - Lundgren, Kalle Conneryd AU - Dillner, Joakim TI - Predicting past and future SARS-CoV-2-related sick leave using discrete time Markov modelling AID - 10.1101/2022.04.22.22274163 DP - 2022 Jan 01 TA - medRxiv PG - 2022.04.22.22274163 4099 - http://medrxiv.org/content/early/2022/04/22/2022.04.22.22274163.short 4100 - http://medrxiv.org/content/early/2022/04/22/2022.04.22.22274163.full AB - Background Prediction of SARS-CoV-2-induced sick leave among healthcare workers (HCWs) is essential for being able to plan the healthcare response to the epidemic.Methods During first wave of the SARS-Cov-2 epidemic (April 23rd to June 24th, 2020), the HCWs in the greater Stockholm region in Sweden were invited to a study of past or present SARS-CoV-2 infection. We develop a discrete time Markov model using a cohort of 9449 healthcare workers (HCWs) who had complete data on SARS-CoV-2 RNA and antibodies as well as sick leave data for the calendar year 2020. The one-week and standardized longer term transition probabilities of sick leave and the ratios of the standardized probabilities for the baseline covariate distribution were compared with the referent period (an independent period when there were no SARS-CoV-2 infections) in relation to PCR results, serology results and gender.Results The one-week probabilities of transitioning from healthy to partial sick leave or full sick leave during the outbreak as compared to after the outbreak were highest for healthy HCWs testing positive for large amounts of virus (3.69, (95% confidence interval, CI: 2.44-5.59) and 6.67 (95% CI: 1.58-28.13), respectively). The proportion of all sick leaves attributed to COVID-19 during outbreak was at most 55% (95% CI: 50%-59%).Conclusions A robust Markov model enabled use of simple SARS-CoV-2 testing data for quantifying past and future COVID-related sick leave among HCWs, which can serve as a basis for planning of healthcare during outbreaks.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialTrial registration number: ClinicalTrials.gov NCT04411576.Funding StatementThis study was funded by the Karolinska University Hospital (KUH) and the County Council of Stockholm. Role of funder was as employer of the study team, providing facilities and resources and also assisted with enrolment (KUH). The funding agencies had no role in the design, execution, interpretation of the study or in the decision to submit it for publication.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.Not ApplicableThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the National Ethical Review Agency of Sweden (Dnr: 2020-01620).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.Not ApplicableI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Not ApplicableI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Not ApplicableThe data constitutes sensitive data about health of human research subjects and thus cannot be directly deposited openly. However, pseudonymised, individual-level data that allow full replication of the results in this article are available from the corresponding author on reasonable request.